This symposium will showcase how the work of CAT has contributed to the regulatory framework for ATMPs in Europe and to the approval of these innovative products.

It will also outline the evolution of CAT and its adaptation to the challenges posed by novel classes of ATMPs.

The ultimate objective is to ensure that high quality, safe and efficacious products become new treatment options.

Many more novel developments are on the horizon. Each has the possibility to revolutionise patient care, and their own merits and challenges.

You can view the page for the program and watch the complete recording here.